{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Bolt Biotherapeutics, Inc."},"Symbol":{"label":"Symbol","value":"BOLT"},"Address":{"label":"Address","value":"900 CHESAPEAKE DRIVE, REDWOOD, California, 94063, United States"},"Phone":{"label":"Phone","value":"+1 650 665-9295"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems."},"CompanyUrl":{"label":"Company Url","value":"https://www.boltbio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Dawn Colburn","title":"Senior Vice President-Clinical Development"},{"name":"Grant Yonehiro","title":"Chief Operating Officer"},{"name":"John Tomaro","title":"Vice President-Clinical Operations"},{"name":"Priti S. Hegde","title":"Chief Scientific Officer"},{"name":"William P. Quinn","title":"President, Chief Executive Officer, CFO & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}